Nevertheless, further analysis showed that only monocytes expressing Cxcl10 were destroyed by the antibody treatment concluding that the Cxcl10+ cells were primarily responsible for causing MS tissue damage in the brain. Here, CXCL10 is linked to myeloid sarcoma.